Jane Street’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.57M | Sell |
993,208
-11,586
| -1% | -$19.5K | ﹤0.01% | 5548 |
|
|
2025
Q4 | $1.68M | Buy |
1,004,794
+859,931
| +594% | +$1.49M | ﹤0.01% | 5152 |
|
|
2025
Q3 | $245K | Sell |
144,863
-1,361,533
| -90% | -$1.61M | ﹤0.01% | 9299 |
|
|
2025
Q2 | $1.37M | Buy |
1,506,396
+1,438,328
| +2,113% | +$853K | ﹤0.01% | 5055 |
|
|
2025
Q1 | $30.7K | Sell |
68,068
-194,798
| -74% | -$114K | ﹤0.01% | 9086 |
|
|
2024
Q4 | $132K | Buy |
262,866
+142,965
| +119% | +$105K | ﹤0.01% | 8635 |
|
|
2024
Q3 | $109K | Sell |
119,901
-123,054
| -51% | -$114K | ﹤0.01% | 8965 |
|
|
2024
Q2 | $242K | Buy |
242,955
+138,155
| +132% | +$153K | ﹤0.01% | 8127 |
|
|
2024
Q1 | $155K | Sell |
104,800
-59,211
| -36% | -$67.1K | ﹤0.01% | 8329 |
|
|
2023
Q4 | $179K | Buy |
164,011
+121,958
| +290% | +$134K | ﹤0.01% | 8297 |
|
|
2023
Q3 | $49.6K | Buy |
42,053
+18,633
| +80% | +$25.4K | ﹤0.01% | 8159 |
|
|
2023
Q2 | $33K | Sell |
23,420
-573,024
| -96% | -$792K | ﹤0.01% | 8292 |
|
|
2023
Q1 | $895K | Buy |
596,444
+455,199
| +322% | +$635K | ﹤0.01% | 5213 |
|
|
2022
Q4 | $165K | Buy |
141,245
+107,223
| +315% | +$135K | ﹤0.01% | 7807 |
|
|
2022
Q3 | $38K | Sell |
34,022
-24,955
| -42% | -$36.6K | ﹤0.01% | 9023 |
|
|
2022
Q2 | $93K | Sell |
58,977
-65,233
| -53% | -$86K | ﹤0.01% | 8678 |
|
|
2022
Q1 | $191K | Sell |
124,210
-141,866
| -53% | -$220K | ﹤0.01% | 9062 |
|
|
2021
Q4 | $652K | Buy |
266,076
+203,527
| +325% | +$476K | ﹤0.01% | 6768 |
|
|
2021
Q3 | $158K | Sell |
62,549
-165,517
| -73% | -$425K | ﹤0.01% | 9025 |
|
|
2021
Q2 | $650K | Buy |
228,066
+157,525
| +223% | +$408K | ﹤0.01% | 6745 |
|
|
2021
Q1 | $166K | Buy |
70,541
+39,826
| +130% | +$95.6K | ﹤0.01% | 8396 |
|
|
2020
Q4 | $54K | Sell |
30,715
-153,025
| -83% | -$214K | ﹤0.01% | 7305 |
|
|
2020
Q3 | $172K | Sell |
183,740
-812,515
| -82% | -$718K | ﹤0.01% | 6519 |
|
|
2020
Q2 | $867K | Buy |
996,255
+806,304
| +424% | +$710K | ﹤0.01% | 4271 |
|
|
2020
Q1 | $157K | Buy |
189,951
+141,483
| +292% | +$141K | ﹤0.01% | 4761 |
|
|
2019
Q4 | $43K | Buy |
48,468
+22,300
| +85% | +$18.6K | ﹤0.01% | 4919 |
|
|
2019
Q3 | $26K | Sell |
26,168
-85,650
| -77% | -$88.7K | ﹤0.01% | 4941 |
|
|
2019
Q2 | $123K | Sell |
111,818
-68,569
| -38% | -$79K | ﹤0.01% | 4811 |
|
|
2019
Q1 | $236K | Buy |
180,387
+97,757
| +118% | +$122K | ﹤0.01% | 4500 |
|
|
2018
Q4 | $76K | Buy |
82,630
+50,263
| +155% | +$77K | ﹤0.01% | 4665 |
|
|
2018
Q3 | $67K | Buy |
+32,367
| New | +$68K | ﹤0.01% | 4899 |
|
|
2018
Q1 | – | Sell |
-44,567
| Closed | -$84K | – | 5177 |
|
|
2017
Q4 | $84K | Sell |
44,567
-6,351
| -12% | -$13.9K | ﹤0.01% | 4360 |
|
|
2017
Q3 | $127K | Buy |
50,918
+24,892
| +96% | +$61.7K | ﹤0.01% | 4229 |
|
|
2017
Q2 | $72K | Sell |
26,026
-79,913
| -75% | -$223K | ﹤0.01% | 4200 |
|
|
2017
Q1 | $320K | Buy |
105,939
+17,236
| +19% | +$48.9K | ﹤0.01% | 3356 |
|
|
2016
Q4 | $280K | Sell |
88,703
-7,962
| -8% | -$24.4K | ﹤0.01% | 3425 |
|
|
2016
Q3 | $330K | Buy |
+96,665
| New | +$267K | ﹤0.01% | 3208 |
|
|
2016
Q2 | – | Sell |
-91,080
| Closed | -$229K | – | 4394 |
|
|
2016
Q1 | $229K | Buy |
+91,080
| New | +$203K | ﹤0.01% | 3543 |
|
|
2015
Q4 | – | Sell |
-155,199
| Closed | -$376K | – | 4292 |
|
|
2015
Q3 | $376K | Buy |
+155,199
| New | +$402K | 0.01% | 2569 |
|
|
2014
Q3 | – | Sell |
-28,036
| Closed | -$69K | – | 2854 |
|
|
2014
Q2 | $69K | Buy |
+28,036
| New | +$63.3K | ﹤0.01% | 2404 |
|
Other funds holding LCTX
BC
VCM
DC
RA
AC
